| Announce Date | 11/17/2025 |
| EPS Normalized Actual | $3.87 (Beat by $2.72) |
| EPS GAAP Actual | $3.87 (Beat by $2.72) |
| Revenue Actual | $18.338B |
| Revenue Surprise | Beat by $18338M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $6.66679 |
| EPS GAAP Estimate | $6.66679 |
| Revenue Estimate | $2.238962393B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 52.7847 | 1.03 | 50.50899 | 54.73236 | 6 |
| Dec 2029 | 48.68359 | 1.12 | 47.3873 | 49.80836 | 4 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 30.36 | 21.96617 | 18.338B | 13.44% | 15783.18M |
| FQ2 2025 (Jun 2025) | 7.34 | 0.92877 | 14.843B | 13.95% | 12722.73M |
| FQ1 2025 (Mar 2025) | 6.48 | 1.2203 | 13.83B | 13.92% | 11923.88M |
| FQ4 2024 (Dec 2024) | 3.09 | -1.29368 | 12.744B | 18.98% | 11070.44M |
| FQ3 2024 (Sep 2024) | 0 | -1.54141 | 15.873B | 13.44% | -9432.75M |
| FQ2 2024 (Jun 2024) | 0 | 0 | 12.772B | 11.94% | 12772M |
| FQ1 2024 (Mar 2024) | 6.62 | 6.62 | 11.905B | 22.74% | 11905M |
| FQ4 2023 (Dec 2023) | 1.94 | 1.94 | 10.325B | 51.31% | 10325M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
6.66679
Consensus Revenue Estimates
2.238962393B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 7.01299 | -- | 6.9107 | 7.1906 | 2 |
| FQ3 2027 (Sep 2027) | 12.53963 | -- | 12.35673 | 12.85721 | 2 |
| FQ2 2027 (Jun 2027) | 9.09637 | -- | 8.96369 | 9.32675 | 2 |
| FQ1 2027 (Mar 2027) | 8.32819 | -- | 8.20672 | 8.53911 | 2 |
| FQ4 2026 (Dec 2026) | 6.77072 | -- | 6.69165 | 6.8562 | 1 |
| FQ3 2026 (Sep 2026) | 10.22599 | -196.89 | 10.10657 | 10.3551 | 1 |
| FQ2 2026 (Jun 2026) | 8.10837 | 9.48 | 8.01368 | 8.21074 | 1 |
| FQ1 2026 (Mar 2026) | 6.66679 | 2.8 | 6.58893 | 6.75096 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 19.17B | -- | 18.96B | 19.54B | 8 |
| FQ3 2027 (Sep 2027) | 25.2B | -- | 24.92B | 25.69B | 5 |
| FQ2 2027 (Jun 2027) | 19.71B | -- | 19.49B | 20.1B | 4 |
| FQ1 2027 (Mar 2027) | 19.21B | -- | 18.99B | 19.58B | 8 |
| FQ4 2026 (Dec 2026) | 2.33B | -- | 2.31B | 2.35B | 2 |
| FQ3 2026 (Sep 2026) | 2.99B | -512.42 | 2.97B | 3.02B | 2 |
| FQ2 2026 (Jun 2026) | 2.49B | -496.31 | 2.47B | 2.51B | 2 |
| FQ1 2026 (Mar 2026) | 2.24B | -517.7 | 2.22B | 2.26B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 8.39383 | 30.36 | 21.96617 | 72.35% |
| FQ2 2025 (Jun 2025) | 6.41123 | 7.34 | 0.92877 | 12.65% |
| FQ1 2025 (Mar 2025) | 5.2597 | 6.48 | 1.2203 | 18.83% |
| FQ4 2024 (Dec 2024) | 4.38368 | 3.09 | -1.29368 | -41.87% |
| FQ3 2024 (Sep 2024) | 1.54141 | 0 | -1.54141 | -INF% |
| FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
| FQ1 2024 (Mar 2024) | 6.62 | 6.62 | 100% | |
| FQ4 2023 (Dec 2023) | 1.94 | 1.94 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $2.55B | $18.34B | $15783.18M | 86.07% |
| FQ2 2025 (Jun 2025) | $2.12B | $14.84B | $12722.73M | 85.72% |
| FQ1 2025 (Mar 2025) | $1.91B | $13.83B | $11923.88M | 86.22% |
| FQ4 2024 (Dec 2024) | $1.67B | $12.74B | $11070.44M | 86.87% |
| FQ3 2024 (Sep 2024) | $25.31B | $15.87B | $-9432.75M | -59.43% |
| FQ2 2024 (Jun 2024) | $0B | $12.77B | $12772M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $11.91B | $11905M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $10.33B | $10325M | 100% |